David M Safley

发表

Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.

David J Cohen, D. Cohen, K. Kennedy, 2015, JACC. Cardiovascular interventions.

Comparison of costs between transradial and transfemoral percutaneous coronary intervention: a cohort analysis from the Premier research database.

D. Safley, J. House, S. Marso, 2013, American heart journal.

Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death

J. Spertus, D. Safley, J. House, 2006, Diabetes Care.

Adherence to Guideline‐Recommended Therapy—Including Supervised Exercise Therapy Referral—Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry

Manesh R. Patel, J. Spertus, M. Shishehbor, 2020, Journal of the American Heart Association.

Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study

W. Gray, M. Jaff, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of quality of life after repeat versus initial coronary artery bypass grafting.

J. Spertus, J. House, David M Safley, 2004, The American journal of cardiology.

Prevalence and predictors of persistent health status impairment in patients referred to a vascular clinic with intermittent claudication.

J. Spertus, M. Flather, David J Cohen, 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome

D. Safley, S. Marso, David M Safley, 2005, Diabetes & vascular disease research.

Diabetes and Percutaneous Coronary Revascularization in the Drug-Eluting Stent Era

D. Safley, S. Marso, David M Safley, 2004, Herz.

Relation of anemia at discharge to survival after acute coronary syndromes.

Randall C. Thompson, H. Krumholz, J. Spertus, 2005, The American journal of cardiology.

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.

J. Spertus, M. Patterson, D. Cohen, 2017, JACC. Cardiovascular interventions.

Training the next generation of invasive cardiologists: Feasibility of implementing a trans-radial access program at an academic hospital.

K. Kennedy, D. Safley, J. Stolker, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Costs of transradial percutaneous coronary intervention.

David J Cohen, A. Chhatriwalla, D. Safley, 2013, JACC. Cardiovascular interventions.

Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions Registry

J. Spertus, T. Tsai, K. Kennedy, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.

J. Spertus, E. Armstrong, W. Jones, 2019, JACC. Cardiovascular interventions.

Treatment decisions for patients with peripheral artery disease and symptoms of claudication: Development process and alpha testing of the SHOW-ME PAD decision aid

Karen R. Sepucha, J. Spertus, K. Sepucha, 2021, Vascular medicine.

Cilostazol and peripheral artery disease-specific health status in ambulatory patients with symptomatic PAD.

J. Spertus, M. Shishehbor, J. Abbott, 2020, International journal of cardiology.

Guideline‐directed statin intensification in patients with new or worsening symptoms of peripheral artery disease

J. Spertus, P. Chan, W. Hiatt, 2018, Clinical cardiology.

Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization

J. Spertus, D. Safley, J. House, 2007, Circulation.

Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery.

C. W. Barth, D. Safley, J. Grantham, 2008, The American journal of cardiology.

Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention.

K. Kennedy, D. Safley, S. Marso, 2011, The American journal of cardiology.

Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

A. Magalski, D. Safley, A. Kao, 2020, Journal of cardiac failure.

Rapidly progressive arterial aneurysms in a patient with Ehlers–Danlos syndrome

J. R. Davis, David M Safley, S. Laster, 2016, Vascular medicine.

Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions.

B. Rutherford, K. Kennedy, D. Safley, 2011 .

Quality of life benefits of percutaneous coronary intervention for chronic occlusions

J. Spertus, D. Safley, J. Grantham, 2022 .

CORONARY ARTERY DISEASE Original Studies Quality of Life Benefits of Percutaneous Coronary Intervention for Chronic Occlusions

J. Spertus, J. Grantham, David M Safley, 2014 .

CORONARY ARTERY DISEASE Original Studies Changes in Myocardial Ischemic Burden Following Percutaneous Coronary Intervention of Chronic Total Occlusions

B. Rutherford, J. Grantham, K. Bybee, 2011 .

E. Mahoney, J. Stolker, J. Yadav, 2022 .

E. Mahoney, D. Cohen, D. Safley, 2022 .

In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.

E. Mahoney, K. Allen, J. House, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions: The CrossBoss First Trial.

C. Don, F. Jaffer, B. Rangan, 2018, JACC. Cardiovascular interventions.

Percutaneous transluminal angioplasty: Association between depressive symptoms and diminished health status benefits

J. Spertus, D. Safley, J. House, 2011, Vascular medicine.

The influence of race on health status outcomes one year after an acute coronary syndrome.

J. Spertus, E. Peterson, D. Safley, 2005, Journal of the American College of Cardiology.

E. Mahoney, J. Stolker, J. Yadav, 2010, JACC. Cardiovascular interventions.

Association between health status and long‐term mortality after percutaneous revascularization of peripheral artery disease

J. Spertus, D. Cohen, D. Safley, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.